BioWorld - Wednesday, February 11, 2026

BioWorld Science

Aug. 9, 2018

View Archived Issues

Plugging leaks in engineered vasculature

Read More

Activin signaling underscores resistance to platinum-based chemotherapy in lung adenocarcinoma

Read More

The exerkine apelin reverses age-associated sarcopenia

Read More

First participant enrolled in phase III study of M-001 universal flu vaccine candidate

Read More

Immunose FLU nasal influenza vaccine candidate demonstrates good safety in older adults

Read More

Phase III study of Estelle oral contraceptive meets primary efficacy endpoint

Read More

Bayer patents MKNK1 inhibitors

Read More

Researchers present new NR1I2 agonists

Read More

Medshine Discovery synthesizes WEE1hu inhibitors

Read More

Description of a phase I study evaluating locoregional immunotherapy for ovarian cancer recurrence

Read More

Positive data announced from phase II extension study of MVA-BN RSV universal vaccine

Read More

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Read More

Identification of genetic prognosticators in glioblastoma survivors by NGS

Read More

Positive topline data presented from the pivotal phase III SONICS study of Recorlev

Read More

Ambys and Takeda to pioneer first-in-class therapies for the treatment of serious liver diseases

Read More

CBT Pharmaceuticals obtains ethics approval in Australia for APOLLO-1 study

Read More

Sangamo reports positive preliminary data from Alta study of gene therapy for hemophilia A

Read More

Phase I study of EGFR CAR T-cell immunotherapy opens

Read More